Stock FATE FATE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Static Chart Fate Therapeutics, Inc.

Equities

FATE

US31189P1021

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-17 pm EDT 		5-day change 1st Jan Change
3.9 USD -5.80% Intraday chart for Fate Therapeutics, Inc. -4.41% +4.28%
May. 10 Piper Sandler Adjusts Fate Therapeutics' Price Target to $4 From $7, Keeps Neutral Rating MT
May. 10 Wedbush Adjusts Fate Therapeutics' Price Target to $5 From $7, Keeps Neutral Rating MT
Chart Fate Therapeutics, Inc.
  1. Stock Market
  2. Equities
  3. FATE Stock
  4. Charts Fate Therapeutics, Inc.
  5. Static Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW